Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RCOR2 downregulates RNF43 via LSD1-mediated histone demethylation in cancer cells

ABSTRACT: RCOR2 downregulates RNF43 via LSD1-mediated histone demethylation in cancer cells

PROVIDER: PRJNA1124114 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RCOR2 downregulates RNF43 via LSD1-mediated histone demethylation in cancer cells

Project description:RCOR2 and LSD1 directly co-binds to RNF43 gene. RCOR2 knockout does not affect LSD1 binding on RNF43 gene.

2025-06-28 | GSE269916 | GEO

RCOR2 downregulates CIITA via HDAC1-mediated histone deacetylation in cancer cells [ChIP-seq]

Project description:RCOR2 and HDAC1 directly co-binds to CIITA gene. RCOR2 knockout does not affect HDAC1 binding on CIITA gene. RCOR2 has no binding on most MHCII genes.

2025-06-28 | GSE270024 | GEO

LSD1-RCOR2 binding and LSD1 and BRD9 transcriptome analysis in Merkel cell carcinoma cells

Project description:LSD1-RCOR2 binding and LSD1 and BRD9 transcriptome analysis in Merkel cell carcinoma cells

| PRJNA514030 | ENA

LSD1 Corepressor Rcor2 Orchestrates Neurogenesis in the Developing Mouse Brain

Project description:LSD1 Corepressor Rcor2 Orchestrates Neurogenesis in the Developing Mouse Brain

| PRJNA302273 | ENA

Non-canonical activating roles of RCoR2 sustain transcription in adrenergic neuroblastoma [HiChIP]

Project description:CoREST complexes (LSD1, HDAC1/2 and RCoR1/2/3) are pivotal in neurodevelopment and have long been recognized as transcriptional repressors across various cancers. However, distinct roles of RCoR factors remain underexplored. Here, we unveil non-canonical functions of RCoR2 in MYCN-amplified neuroblastoma (NB), underscoring its unique significance compared to its paralogues. This insight shifts the paradigm, highlighting RCoR2 as a key determinant of the NB chromatin landscape. Our findings demonstrate that RCoR2 is a super-enhancer driven gene, which, unlike RCoR1, acts as a positive regulator of gene expression as a partner of the adrenergic NB core regulatory circuitry (CRC). We propose a model in which RCoR2 facilitates interactions between CRC-bound enhancers and their associated transcription start sites, thereby sustaining the expression of genes critical for neuroblastoma cell survival. Thus, we identify RCoR2 as a critical vulnerability in high-risk neuroblastoma and a promising target for cancer therapeutics.

2025-06-10 | GSE281089 | GEO